ID
BSX icon

Integral Derivatives’s Boston Scientific BSX Stock Holding History

Integral Derivatives’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-84,400
Closed -$2.09M – 703
2017
Q4 		$2.09M Sell
84,400
-36,500
-30% -$1.01M 0.04% 284
2017
Q3 		$3.53M Buy
120,900
+2,500
+2% +$69K 0.06% 196
2017
Q2 		$3.28M Buy
118,400
+84,100
+245% +$2.23M 0.07% 184
2017
Q1 		$853K Sell
34,300
-38,500
-53% -$936K 0.02% 572
2016
Q4 		$1.57M Buy
72,800
+44,800
+160% +$978K 0.03% 378
2016
Q3 		$666K Sell
28,000
-10,900
-28% -$260K 0.01% 543
2016
Q2 		$909K Buy
38,900
+13,900
+56% +$301K 0.02% 441
2016
Q1 		$470K Buy
+25,000
New +$439K 0.02% 538
2015
Q2 		– Sell
-13,900
Closed -$247K – 1108
2015
Q1 		$247K Sell
13,900
-27,800
-67% -$439K 0.01% 903
2014
Q4 		$553K Buy
41,700
+14,000
+51% +$179K 0.01% 887
2014
Q3 		$327K Sell
27,700
-22,600
-45% -$285K 0.01% 1105
2014
Q2 		$642K Hold
50,300
– – 0.01% 853
2014
Q1 		$680K Buy
50,300
+25,300
+101% +$332K 0.01% 784
2013
Q4 		$300K Buy
+25,000
New +$295K ﹤0.01% 1211

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Integral Derivatives's BSX Position: Q1 2014 in Review

Integral Derivatives sold out of Boston Scientific (BSX) in Q1 2014, closing a stake of 61,600 shares — an estimated $809K sold.

Integral Derivatives first reported a position in BSX in Q4 2013 and held it in 1 quarter. The position peaked at $740K in Q4 2013. 440 funds tracked by Wall St. Rank hold BSX as of Q1 2014.

  • Integral Derivatives reported no remaining Boston Scientific position as of Q1 2014 after selling out during the quarter.
  • Integral Derivatives sold 61,600 Boston Scientific shares in Q1 2014, an estimated $809K.
  • Integral Derivatives first reported a position in Boston Scientific in Q4 2013 and held it in 1 quarter.
  • Integral Derivatives's Boston Scientific position peaked at $740K in Q4 2013.
  • 440 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2014.

Based on Integral Derivatives's 13F filing for Q1 2014, filed 2 May 2014.